glp-1 agonists for weight loss medications GLP-1 Drugs for Weight Loss:
Description
The oral formulation is the most significant differentiator: if an oral tablet can produce weight loss comparable to injectable CagriSema, it could fundamentally change how dual pathway obesity therapy is delivered
1 Excess adiposity is a major contributor to BP elevation, with estimates suggesting that obesity causes 65%-78% of primary hypertension cases
However, due to the black box warning of suicidality, this medicine should be avoided in adolescents or monitored very closely if prescribed
Meta-analysis of these eight CVOTs with 60 080 patients included showed that GLP-1 receptor agonists reduce MACE and have a positive impact on chronic kidney disease in patients with T2D ( Dose-dependent effect for oral semaglutide was assessed and proven in Japanese PIONEER 9 trial, where greater reduction of HbA1c and weight loss was achieved with higher dose of oral semaglutide compared to placebo and 0.9 mg liraglutide (46)
Garvey WT, Duque do Vale R, Karlsson T, Lingvay I, Chaithra S, Rubino DM
Tirzepatide reduces appetite, energy intake, and fat mass in people with T2D (abstract)
